 |
市場調查報告書
商品編碼
1907927
脂質體市場按類型、結構、脂質組成、製劑技術、載藥方法、應用、給藥途徑、最終用戶和地區分類Liposomes Market, By Type, By Structure, By Lipid Composition, By Technique of Preparation, By Drug Loading Method, By Application, By Route of Administration, By End User, By Geography |
||||||
價格
簡介目錄
預計到 2025 年，脂質體市值將達到 53.4 億美元，到 2032 年將達到 100.8 億美元，2025 年至 2032 年的複合年成長率為 9.5%。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2024 | 市場規模（2025 年） | 53.4億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期（2025-2032 年）複合年成長率 | 9.50% | 預計金額（2032 年） | 100.8億美元 |
全球脂質體市場是製藥和生物技術產業中一個快速發展的細分市場，其特點是利用磷脂基囊泡結構來增強治療效果的先進藥物傳遞系統。
脂質體作為一種生物相容性和生物可分解的載體，透過提供一種標靶藥物遞送機制，徹底改變了製藥業。這種機制顯著提高了藥物的生物利用度，同時最大限度地減少了副作用。這些微小的球形囊泡由一層或多層磷脂雙分子層包裹的水性核心組成，是封裝親水性和疏水性藥物、蛋白質、胜肽和遺傳物質的理想平台。
市場擴張的促進因素包括慢性病盛行率的上升、對個人化醫療日益成長的需求以及對奈米技術藥物遞送系統的大量投資。脂質體在腫瘤學、感染疾病、眼科和疫苗研發等許多領域都有應用，展現出在多個醫學領域改善治療效果的巨大潛力。
先進製造技術的整合，加上創新脂質體配方的監管核准，使該市場成為現代藥物開發策略的關鍵組成部分，吸引了許多成熟製藥公司和尋求利用下一代藥物輸送解決方案的新興生物技術公司的注意。
市場動態
全球脂質體市場受多種強勁的市場促進因素所推動。其中最主要的促進因素是全球癌症和慢性疾病的日益普遍，這迫切需要更有效、更具針對性的治療性介入，而脂質體藥物遞送系統恰恰能夠滿足這一需求。此外，人口老化加劇、醫療保健支出不斷成長以及人們對先進藥物遞送機制的認知不斷提高，也顯著促進了市場的擴張。
脂質體生產流程的技術進步，例如遠端裝載技術和隱形脂質體開發，提高了產品的穩定性和治療效果，促使製藥公司對脂質體製劑進行大量投資。然而，市場也面臨著許多限制因素，包括脂質體產品高昂的研發和生產成本、複雜的監管核准流程導致產品上市時間延長，以及在維持產品品質和均一性的同時擴大生產規模所面臨的技術挑戰。
其他挑戰包括現有脂質體製劑的專利到期以及其他藥物遞送系統的激烈競爭。儘管有這些限制，脂質體在基因治療、疫苗研發和個人化醫療領域日益廣泛的應用也帶來了巨大的機會。
對罕見疾病治療日益成長的關注、新興市場對脂質體製劑的日益普及，以及其在化妝品和營養保健品領域的潛在應用，都預示著脂質體藥物遞送系統盈利的成長潛力。製藥公司與研究機構之間的策略合作，以及政府對奈米技術研究的支持，都為脂質體藥物遞送系統的市場擴張和創新創造了有利環境。
本報告的主要特點
- 本報告對全球脂質體市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和複合年成長率，以 2024 年為基準年。
- 它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
- 全球脂質體市場的主要企業將根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
- 《全球脂質體市場》報告面向該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過用於分析全球脂質體市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 分析目標和先決條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進要素
- 抑制因素
- 機會
- 影響分析
- 重大進展
- 監管情景
- 產品發布/核准
- PEST分析
- 波特五力分析
- 企業合併情景
- 產業趨勢
第4章 全球脂質體市場（按類型分類）（2020-2032 年）
- 傳統脂質體
- 聚乙二醇化脂質體
- 配體標靶脂質體
- 長循環（隱形）脂質體
- pH敏感脂質體
- 溫度敏感脂質體
- 陽離子脂質體
5. 全球脂質體市場依結構分類（2020-2032 年）
- 多層囊泡
- 小單層囊泡
- 大型單層囊泡
- 巨型單層囊泡
6. 全球脂質體市場依脂質組成分類（2020-2032 年）
- 基於磷脂的脂質體
- 富含膽固醇的脂質體
- 基於鞘磷脂的脂質體
- 合成脂質體（DSPC、DOPC 等）
- 天然脂質體
7. 全球脂質體市場依製劑技術分類（2020-2032 年）
- 薄膜水化法
- 反相蒸發
- 乙醇注射法
- 基於微流體技術的製造
- 去除清潔劑的方法
- 凍融法
- 高壓均質化
8. 全球脂質體市場依載藥方法分類（2020-2032 年）
- 被動負載
- 活性負載（pH梯度、硫酸銨梯度）
9. 全球脂質體市場按應用領域分類（2020-2032 年）
- 藥物遞送
- 腫瘤學
- 感染疾病
- 心血管疾病
- 神經系統疾病
- 皮膚科
- 基因轉移
- 疫苗接種
- 化妝品和個人護理
- 營養補充品
- 診斷和影像診斷
10. 全球脂質體市場依給藥途徑分類（2020-2032 年）
- 靜脈注射
- 肌肉內注射
- 皮下
- 口服
- 外用
- 吸入
第11章 全球脂質體市場（以最終用戶分類）（2020-2032 年）
- 製藥和生物技術公司
- 學術和研究機構
- 醫院和診所
- 化妝品和個人護理用品製造商
- 合約研究與生產組織（CRO/CMO）
第12章 全球脂質體市場（按地區分類）（2020-2032 年）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第13章 競爭格局
- Gilead Sciences
- Johnson and Johnson
- Sun Pharmaceutical Industries
- Pacira BioSciences
- Luye Pharma Group
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries
- Novartis
- Ipsen
- Bristol Myers Squibb
- Pfizer
- Merck
- Evonik Health Care
- Fujifilm
- Polymun Scientific
第14章 分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map (COM)
第15章 參考文獻與分析方法
- 參考
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI9056
Liposomes Market is estimated to be valued at USD 5.34 Bn in 2025 and is expected to reach USD 10.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 5.34 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.50% | 2032 Value Projection: | USD 10.08 Bn |
The global liposomes market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, characterized by sophisticated drug delivery systems that leverage phospholipid-based vesicular structures to enhance therapeutic efficacy.
Liposomes, as biocompatible and biodegradable carriers, have revolutionized the pharmaceutical landscape by offering targeted drug delivery mechanisms that significantly improve bioavailability while minimizing adverse effects. These microscopic spherical vesicles, composed of one or more phospholipid bilayers surrounding an aqueous core, serve as versatile platforms for encapsulating both hydrophilic and lipophilic drugs, proteins, peptides, and genetic materials.
The market's expansion is driven by increasing prevalence of chronic diseases, growing demand for personalized medicine, and substantial investments in nanotechnology-based drug delivery systems. With applications spanning oncology, infectious diseases, ophthalmology, and vaccine development, liposomes have demonstrated remarkable potential in enhancing therapeutic outcomes across diverse medical fields.
The integration of advanced manufacturing technologies, coupled with regulatory approvals for innovative liposomal formulations, has positioned this market as a critical component of modern pharmaceutical development strategies, attracting significant attention from both established pharmaceutical companies and emerging biotechnology firms seeking to capitalize on next-generation drug delivery solutions.
Market Dynamics
The global liposomes market is propelled by several compelling drivers, primarily the escalating prevalence of cancer and chronic diseases worldwide, which necessitates more effective and targeted therapeutic interventions that liposomal drug delivery systems uniquely provide. The growing geriatric population, coupled with increasing healthcare expenditure and rising awareness about advanced drug delivery mechanisms, significantly contributes to market expansion.
Technological advancements in liposome manufacturing processes, including remote loading techniques and stealth liposome development, have enhanced product stability and therapeutic efficacy, driving pharmaceutical companies to invest heavily in liposomal formulations. However, the market faces notable restraints including high development and manufacturing costs associated with liposomal products, complex regulatory approval processes that extend time-to-market, and technical challenges related to scale-up production while maintaining product quality and consistency.
Patent expirations of established liposomal drugs and intense competition from alternative drug delivery systems pose additional challenges. Despite these constraints, significant opportunities emerge from the expanding applications of liposomes in gene therapy, vaccine development, and personalized medicine sectors.
The growing focus on rare disease treatments, increasing adoption of liposomal formulations in emerging markets, and potential applications in cosmetics and nutraceuticals present lucrative growth avenues. Strategic collaborations between pharmaceutical companies and research institutions, along with government initiatives supporting nanotechnology research, create favorable conditions for market expansion and innovation in liposomal drug delivery systems.
Key Features of the Study
- This report provides in-depth analysis of the global liposomes market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global liposomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Gilead Sciences, Johnson and Johnson, Sun Pharmaceutical Industries, Pacira BioSciences, Luye Pharma Group, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Novartis, Ipsen, Bristol Myers Squibb, Pfizer, Merck, Evonik Health Care, Fujifilm, and Polymun Scientific
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global liposomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposomes market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Conventional Liposomes
- PEGylated Liposomes
- Ligand-Targeted Liposomes
- Long-Circulating (Stealth) Liposomes
- pH-Sensitive Liposomes
- Temperature-Sensitive Liposomes
- Cationic Liposomes
- Structure Insights (Revenue, USD Bn, 2020 - 2032)
- Multilamellar Vesicles
- Small Unilamellar Vesicles
- Large Unilamellar Vesicles
- Giant Unilamellar Vesicles
- Lipid Composition Insights (Revenue, USD Bn, 2020 - 2032)
- Phospholipid-Based Liposomes
- Cholesterol-Enriched Liposomes
- Sphingomyelin-Based Liposomes
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Natural Lipid Liposomes
- Technique of Preparation Insights (Revenue, USD Bn, 2020 - 2032)
- Thin Film Hydration
- Reverse-Phase Evaporation
- Ethanol Injection
- Microfluidics-Based Production
- Detergent Removal
- Freeze-Thaw Method
- High-Pressure Homogenization
- Drug Loading Method Insights (Revenue, USD Bn, 2020 - 2032)
- Passive Loading
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Delivery
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Dermatology
- Gene Delivery
- Vaccine Delivery
- Cosmetics and Personal Care
- Nutraceuticals
- Diagnostics and Imaging
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous
- Intramuscular
- Subcutaneous
- Oral
- Topical
- Inhalation
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinics
- Cosmetics and Personal Care Manufacturers
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Gilead Sciences
- Johnson and Johnson
- Sun Pharmaceutical Industries
- Pacira BioSciences
- Luye Pharma Group
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries
- Novartis
- Ipsen
- Bristol Myers Squibb
- Pfizer
- Merck
- Evonik Health Care
- Fujifilm
- Polymun Scientific
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Liposomes Market, By Type
- Global Liposomes Market, By Structure
- Global Liposomes Market, By Lipid Composition
- Global Liposomes Market, By Technique of Preparation
- Global Liposomes Market, By Drug Loading Method
- Global Liposomes Market, By Application
- Global Liposomes Market, By Route of Administration
- Global Liposomes Market, By End User
- Global Liposomes Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Liposomes Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Conventional Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- PEGylated Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ligand-Targeted Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Long-Circulating (Stealth) Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- pH-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Temperature-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cationic Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Liposomes Market, By Structure, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Multilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Small Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Large Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Giant Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Liposomes Market, By Lipid Composition, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Phospholipid-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cholesterol-Enriched Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sphingomyelin-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Natural Lipid Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Liposomes Market, By Technique of Preparation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Thin Film Hydration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reverse-Phase Evaporation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ethanol Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microfluidics-Based Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Detergent Removal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Freeze-Thaw Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High-Pressure Homogenization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Liposomes Market, By Drug Loading Method, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Passive Loading
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Liposomes Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccine Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cosmetics and Personal Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostics and Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Liposomes Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Liposomes Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cosmetics and Personal Care Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Liposomes Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacira BioSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luye Pharma Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ipsen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evonik Health Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Polymun Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
